AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

OPKO Health Inc. (OPK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.68

-0.03 (-1.75%)

At close: Feb 20, 2025, 3:59 PM

1.68

0.30%

After-hours: Feb 20, 2025, 05:51 PM EST

undefined% (undefined)

Bid	1.65
Market Cap	1.14B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.19
PE Ratio (ttm)	-8.82
Forward PE	n/a
Analyst	Buy

Ask	1.68
Volume	1,587,573
Avg. Volume (20D)	3,418,733
Open	1.70
Previous Close	1.71
Day's Range	1.67 - 1.72
52-Week Range	0.86 - 1.76
Beta	undefined

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, geneti...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Nov 2, 1995

Employees 3,930

Stock Exchange NASDAQ

Ticker Symbol OPK

Website https://www.opko.com

Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for OPK stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 79.10% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

OPKO Health Inc. is scheduled to release its earnings on Feb 27, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+4.14%

Merck & Compnay and OPKO Health shares are trading... Unlock content with Pro Subscription

6 months ago

+11.72%

OPKO Health shares are trading higher after the company reported better-than-expected Q2 EPS results.

News

1 month ago · zacks.com

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

OPK's growth is fueled by Rayaldee's success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns.

1 month ago · zacks.com

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains

OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.

1 month ago · marketbeat.com

3 Stocks That Wall Street Insiders Can't Stop Buying

Insider activity is hot in names like Vestis NYSE: VSTS, OPKO Health NASDAQ: OPK, and Greif, Inc. NYSE: GEF, and investors should take notice. From board members to CEOs, CFOs, and other corporate off...